1. Home
  2. CRSP vs NXST Comparison

CRSP vs NXST Comparison

Compare CRSP & NXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$54.91

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Logo Nexstar Media Group Inc.

NXST

Nexstar Media Group Inc.

HOLD

Current Price

$163.57

Market Cap

5.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSP
NXST
Founded
2013
1996
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.4B
IPO Year
2016
2002

Fundamental Metrics

Financial Performance
Metric
CRSP
NXST
Price
$54.91
$163.57
Analyst Decision
Buy
Strong Buy
Analyst Count
17
8
Target Price
$70.29
$263.75
AVG Volume (30 Days)
1.6M
371.5K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
3.67%
EPS Growth
N/A
N/A
EPS
N/A
5.09
Revenue
$289,590,000.00
$4,949,000,000.00
Revenue This Year
$807.72
$11.38
Revenue Next Year
$172.52
N/A
P/E Ratio
N/A
$30.39
Revenue Growth
9169.85
N/A
52 Week Low
$44.12
$154.47
52 Week High
$78.48
$254.30

Technical Indicators

Market Signals
Indicator
CRSP
NXST
Relative Strength Index (RSI) 53.13 35.56
Support Level $50.17 N/A
Resistance Level $60.10 $210.51
Average True Range (ATR) 2.57 6.72
MACD 0.19 -0.67
Stochastic Oscillator 60.16 28.10

Price Performance

Historical Comparison
CRSP
NXST

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About NXST Nexstar Media Group Inc.

Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Assuming its merger with Tegna is affirmed Nexstar's station total would exceed 259 and reach 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.

Share on Social Networks: